Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows provided by (used in) operating activities:
Net earnings	$ 238.3	$ 182.6
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization	270.0	254.4
Share-based compensation	24.2	19.6
Changes in operating assets and liabilities, net of acquired assets and liabilities
Income taxes	(7.4)	(15.6)
Receivables	14.5	(18.8)
Inventories	(20.9)	(3.0)
Accounts payable and accrued liabilities	(183.0)	(36.4)
Other assets and liabilities	23.5	(0.1)
Net cash provided by operating activities	359.4	382.8
Cash flows provided by (used in) investing activities:
Additions to instruments	(77.2)	(59.7)
Additions to other property, plant and equipment	(36.3)	(44.6)
Net investment hedge settlements	(0.3)	1.0
Acquisition of intangible assets	(39.0)	(2.4)
Other investing activities	(6.2)	(0.3)
Net cash used in investing activities	(159.0)	(106.0)
Cash flows provided by (used in) financing activities:
Proceeds from senior notes		1,748.1
Redemption of senior notes		(863.0)
Dividends paid to stockholders	(46.9)	(47.8)
Proceeds from employee stock compensation plans	12.3	16.7
Business combination contingent consideration payments	(69.0)	(17.4)
Debt issuance costs		(16.1)
Repurchase of common stock	(250.1)	(229.8)
Other financing activities	(15.6)	(15.2)
Net cash (used in) provided by financing activities	(369.2)	575.4
Effect of exchange rates on cash and cash equivalents	1.1	7.0
Change in cash and cash equivalents	(167.7)	859.1
Cash and cash equivalents, beginning of year	591.9	525.5
Cash and cash equivalents, end of period	$ 424.2	$ 1,384.5